Back

P261
The role of tenascin C under hyperglycaemic and hypertrophic conditions - In vitro H9c2 rat cardiomyoblasts model

Cardiovascular Research

23 April 2018
Organised by: Logo
Read full article
ESC Journals

Contributors

I Fonseca Goncalves
I Fonseca Goncalves

Author

E Acar
E Acar

Author

E V Tretter
E V Tretter

Author

U Klein
U Klein

Author

A Kiss
A Kiss

Author

B K Podesser
B K Podesser

Author

You may be interested in
thumbnail
Congress Presentation
Increased Tenascin-C expression contributes to cardiac dysfunction and fibrosis in Duchenne muscular dystrophy
28 August 2022
thumbnail
Congress Presentation
Regional levels of tenascin- C in patients with heart failure and atrial fibrillation
22 May 2023
thumbnail
Congress Presentation
Metformin treatment in hyperglycemic patients with Ischemia and no obstructive coronary artery
17 May 2025
thumbnail
Congress Presentation
The senolytic agent Dasatinib reduces fat accumulation in the heart and bone marrow of type 2 diabetic, obese mice and adipogenesis of human bone marrow pericytes
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources